Endogenous opiates and behavior: 2012

Richard J Bodnar1

  • 1Department of Psychology and Neuropsychology Doctoral Sub-Program, Queens College, City University of New York, Flushing, NY 11367, United States.

Peptides
|October 16, 2013
PubMed

Keywords:
5-HTACTHANGATPAchBAM22BDNFBENDBFNABNSTBeta-endorphinC/PCARTCBCCKCGRPCPPCRFCTAPCa(2+)DADADLDAMGODORDPDPEDRGDRNDYNDynorphin, Orphanin FQ/nociceptinERKEndomorphinsEnkEnkephalinsFMRIFSHG-protein-coupled receptor kinasesGABAGHRHGIGRKHIVHPAHPLCICSSK(+)KOKORLCLHLPSLTPLenkM3GM6GMAPKMCHMORMSHMenkN-methyl-d-aspartateNACNBNINENMDANONOSNPYNTINTSNa+OFQ/NORL-1OXYOpiate receptorsPAGPBNPCAPDYNPKAPKCPOFQ/NPOMCPTSDPVNPenkRVMSIASNPSPSTZTHCTMJTNFVMHVPVTAacetylcholineadenosine triphosphateadrenocorticotrophic hormoneangiotensinbed nucleus of the stria terminalisbeta-endorphinbeta-funaltrexaminebovine adrenal medulla 22brain-derived neurotrophic factorcalcitonin gene-related peptidecalciumcannabinoidcaudate/putamencholecystokinincocaine and amphetamine-regulated transcriptconditioned place preferencecorticotropin factord-Ala(2),Nme(4),Gly-ol(5)-enkephalind-Ala(2),d-Leu(5)-enkephalind-Pen(2),d-Pen(5)-enkephalind-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2 cyclicdelta opioid receptordopaminedorsal raphe nucleusdorsal root gangliondynorphinenkephalinextracellular regulated signal kinasesfollicle stimulating hormonefunctional magnetic resonance imaginggamma-amino-butyric acidgastrointestinalgrowth hormone releasing hormonehigh-performance liquid chromatographyhuman immunodeficiency virushypothalamus–pituitary–adrenalintracranial self-stimulationkappa opioid receptorknockoutl-3,4-dihydroxyphenylalaninel-DOPAleu-enkephalinleutinizing hormonelipopolysaccharidelocus coeruleuslong-term potentiationmelanin concentrating hormonemelanocyte stimulating hormonemet-enkephalinmitogen-activated protein kinasemorphine-3-glucuronidemorphine-6-glucuronidemu opioid receptornaltrindoleneuropeptide Ynitric oxidenitric oxide synthasenociceptinnor-binaltorphaminenorepinephrinenucleus accumbensnucleus tractus solitariusorphan receptor like receptoroxytocinparabrachial nucleusparaventricular nucleuspatient-controlled analgesiaperiaqueductal graypost-traumatic stress disorderpotassiumpreprodynorphinpreproenkephalinprepronociceptin/orphanin FQpro-opiomelanocortinprotein kinase Aprotein kinase Crostral ventromedial medullaserotoninsingle nucleotide polymorphismsodiumstreptozotocinstress-induced analgesiasubstance Ptemporomandibular jointtetrahydrocannibinoltumor necrosis factorvasopressinventral tegmental areaventromedial nucleus of the hypothalamus

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.4K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.6K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K